Organon Pharma Indonesia Tbk. vs Asuransi Digital Bersama Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Asuransi Digital Bersama Tbk. trades at Rp80 (market cap 322.01B, 2.76M 24h volume). The key difference: Asuransi Digital Bersama Tbk. is far larger — about 3.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | YOII | |
|---|---|---|
Market Cap | 104.4B | 322.01B |
Volume | — | 2.76M |
Lot | — | 27.61K |
Turnover | — | 221.21M |
Average Price | — | 80.11 |
Value | — | 221.21M |
Indicative Equilibrium Price | — | 80 |
Indicative Equilibrium Volume | — | 71 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Asuransi Digital Bersama Tbk (The Company) was established as PT Sarana Lindung Upaya based on Notarial Deed No. 48 dated April 25, 1987 amended with Jo No. 25 dated October 9, 1987 and Jo No. 29 dated January 20, 1988 of Joeni Moeljani, S.H., a notary in Semarang. The Company started its commercial operations in June 1988.
Read more on YOII →